These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 7897381
1. Interruption of an outbreak of hepatitis A in two villages by vaccination. Príkazský V, Oleár V, Cernoch A, Safary A, André FE. J Med Virol; 1994 Dec; 44(4):457-9. PubMed ID: 7897381 [Abstract] [Full Text] [Related]
2. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. Arch Pediatr Adolesc Med; 1996 Jul; 150(7):733-9. PubMed ID: 8673200 [Abstract] [Full Text] [Related]
3. Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A. Craig AS, Sockwell DC, Schaffner W, Moore WL, Skinner JT, Williams IT, Shaw FE, Shapiro CN, Bell BP. Clin Infect Dis; 1998 Sep; 27(3):531-5. PubMed ID: 9770153 [Abstract] [Full Text] [Related]
4. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1996 Dec 27; 45(RR-15):1-30. PubMed ID: 9005304 [Abstract] [Full Text] [Related]
5. Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks. Kohl I, Nemecek V, Summerová M, Chlíbek R, Nad'ová K, Mináriková O. Eur J Epidemiol; 2006 Dec 27; 21(12):893-9. PubMed ID: 17160428 [Abstract] [Full Text] [Related]
6. Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine. Zamir C, Rishpon S, Zamir D, Leventhal A, Rimon N, Ben-Porath E. Eur J Clin Microbiol Infect Dis; 2001 Mar 27; 20(3):185-7. PubMed ID: 11347668 [Abstract] [Full Text] [Related]
7. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. J Med Virol; 1994 Dec 27; 44(4):446-51. PubMed ID: 7897379 [Abstract] [Full Text] [Related]
13. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998. Deshaies D, Dion R, Valiquette L, Auger N. Can Commun Dis Rep; 1998 Sep 15; 24(18):145-51. PubMed ID: 9780447 [No Abstract] [Full Text] [Related]
14. Immunogenicity of inactivated hepatitis A vaccine in children. Lee SD, Lo KJ, Chan CY, Yu MY, Wang YJ, Safary A. Gastroenterology; 1993 Apr 15; 104(4):1129-32. PubMed ID: 8462802 [Abstract] [Full Text] [Related]
16. Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A. Zuckerman JN, Kirkpatrick CT, Huang M. J Travel Med; 1998 Mar 15; 5(1):18-22. PubMed ID: 9772311 [Abstract] [Full Text] [Related]
17. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G, Belmaker I, Givon-Lavi N, Dagan R. Pediatr Infect Dis J; 2009 May 15; 28(5):391-3. PubMed ID: 19295466 [Abstract] [Full Text] [Related]
19. Advances in hepatitis A prevention in travellers. Steffen R, Gyurech D. J Med Virol; 1994 Dec 15; 44(4):460-2. PubMed ID: 7897382 [Abstract] [Full Text] [Related]